Related Experiment Video
Updated: May 29, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Comparative antimutagenic and anticancer activity of three fractions of black tea polyphenols thearubigins
Udayan Bhattacharya1, Sibabrata Mukhopadhyay, Ashok K Giri
1Molecular and Human Genetics Division, Indian Institute of Chemical Biology, Kolkata, India.
Abstract:
Antimutagenic and anticancer effects of black tea polyphenols theaflavins (TF) and thearubigins (TR) have previously been reported. TR is a complex mixture of polyphenols. In this study, our interest was to fractionate TR and to study the antimutagenic and anticancer activities of the fractions. Three fractions of TR, namely TR-1, TR-2, and TR-3, were isolated by chromatographic processes. Antimutagenic activity of these 3 fractions was carried out on 4 Salmonella strains by Ames assay. Anticancer activity was studied on human leukemic cells U937. Our findings clearly indicated antimutagenic and anticancer activities of the TR-1, TR-2, and TR-3 fractions on Salmonella strains and on U937 cells, respectively. However, all 3 fractions, at or below 100 μg/ml dose, did not show any significant toxic effects on the normal human cells (peripheral blood mononuclear cells). TR-2 was found to be the most active fraction among the 3. Flow cytometric and confocal microscopic studies further indicate that apoptosis induction could be an important mechanism behind the anticancer effects of these fractions. To our knowledge, this study is the first attempt to describe the antimutagenic and anticancer activity of TR fractions, and it also suggests that TR-2 is the most active component of TR.
Insights
Black tea polyphenols, thearubigins (TR), were fractionated to assess their health benefits. The TR-2 fraction demonstrated significant antimutagenic and anticancer effects without harming normal cells, suggesting its therapeutic potential.
Area of Science:
- Food Science
- Biochemistry
- Pharmacology
Background:
- Black tea polyphenols, including theaflavins (TF) and thearubigins (TR), are known for their potential health benefits.
- Thearubigins (TR) represent a complex mixture of polyphenols with largely uncharacterized biological activities.
Purpose of the Study:
- To fractionate thearubigins (TR) from black tea.
- To evaluate the antimutagenic and anticancer properties of isolated TR fractions.
- To identify the most active TR fraction and investigate its mechanism of action.
Main Methods:
- Chromatographic separation was used to isolate three fractions (TR-1, TR-2, TR-3) from thearubigins (TR).
- Antimutagenic activity was assessed using the Ames assay on four Salmonella strains.
- Anticancer activity was evaluated on human leukemic U937 cells and normal peripheral blood mononuclear cells.
- Apoptosis induction was studied using flow cytometry and confocal microscopy.
Main Results:
- All three TR fractions (TR-1, TR-2, TR-3) exhibited significant antimutagenic and anticancer activities.
- None of the fractions showed significant toxicity to normal human cells at concentrations up to 100 μg/ml.
- The TR-2 fraction was identified as the most potent among the tested fractions.
- Apoptosis induction was suggested as a key mechanism underlying the observed anticancer effects.
Conclusions:
- Fractionation of thearubigins (TR) yields components with distinct biological activities.
- The TR-2 fraction possesses notable antimutagenic and anticancer properties with a favorable safety profile.
- This study provides the first evidence for the specific activities of TR fractions, highlighting TR-2 as a promising therapeutic agent.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity